ET-1 dependent vasoconstrictor tone has been shown to increase in patients affected by hypertension [30], hypercholesterolemia [31], T2DM [32,33], and metabolic syndrome, coexisting with an impaired NO bioactivity in the vasculature of these patients [24]. Here, EDN1 is linked to metabolic syndrome.